(Q35564266)

8 August 2017

1 reference

title

The role of chemokines in the pathogenesis of scleroderma (English)

1 reference

https://api.crossref.org/works/10.1097/00002281-200311000-00015

23 March 2024

1 reference

https://api.crossref.org/works/10.1097/00002281-200311000-00015

23 March 2024

author name string

Barbara White

2

1 reference

8 August 2017

Sergei P. Atamas

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14569209

23 March 2024

language of work or name

1 reference

1 November 2003

1 reference

full work available at URL

8 August 2017

https://journals.lww.com/00002281-200311000-00015

1 reference

https://api.crossref.org/works/10.1097/00002281-200311000-00015

Current Opinion in Rheumatology

23 March 2024

published in

1 reference

8 August 2017

volume

15

1 reference

8 August 2017

issue

6

1 reference

8 August 2017

page(s)

772-777

1 reference

Deficient Smad7 expression: a putative molecular defect in scleroderma

8 August 2017

cites work

1 reference

9 February 2024

https://opencitations.net/index/api/v1/citations/10.1073/PNAS.062010399

Costimulation of fibroblast collagen and transforming growth factor beta1 gene expression by monocyte chemoattractant protein-1 via specific receptors

1

1 reference

https://api.crossref.org/works/10.1097/00002281-200311000-00015

Overexpression of monocyte chemoattractant protein 1 in systemic sclerosis: role of platelet-derived growth factor and effects on monocyte chemotaxis and collagen synthesis

23 March 2024

2

1 reference

https://api.crossref.org/works/10.1097/00002281-200311000-00015

Chemokine expression by systemic sclerosis fibroblasts: abnormal regulation of monocyte chemoattractant protein 1 expression

23 March 2024

3

1 reference

https://api.crossref.org/works/10.1097/00002281-200311000-00015

Augmented production of chemokines (monocyte chemotactic protein-1 (MCP-1), macrophage inflammatory protein-1alpha (MIP-1alpha) and MIP-1beta) in patients with systemic sclerosis: MCP-1 and MIP-1alpha may be involved in the development of pulmonary

23 March 2024

4

1 reference

https://api.crossref.org/works/10.1097/00002281-200311000-00015

Gene expression in bronchoalveolar lavage cells from scleroderma patients

23 March 2024

5

1 reference

https://api.crossref.org/works/10.1097/00002281-200311000-00015

Expression of monocyte chemoattractant protein-1 in the lesional skin of systemic sclerosis

23 March 2024

6

1 reference

https://api.crossref.org/works/10.1097/00002281-200311000-00015

High expression and autoinduction of monocyte chemoattractant protein-1 in scleroderma fibroblasts

23 March 2024

7

1 reference

https://api.crossref.org/works/10.1097/00002281-200311000-00015

Role of stem cell factor and monocyte chemoattractant protein-1 in the interaction between fibroblasts and mast cells in fibrosis

23 March 2024

8

1 reference

https://api.crossref.org/works/10.1097/00002281-200311000-00015

Alveolar epithelial cell inhibition of fibroblast proliferation is regulated by MCP-1/CCR2 and mediated by PGE2.

23 March 2024

9

1 reference

https://api.crossref.org/works/10.1097/00002281-200311000-00015

Murine sclerodermatous graft-versus-host disease, a model for human scleroderma: cutaneous cytokines, chemokines, and immune cell activation

23 March 2024

10

1 reference

https://api.crossref.org/works/10.1097/00002281-200311000-00015

Chemotactic cytokines mediate leukocyte recruitment in fibrotic lung disease

23 March 2024

12

1 reference

https://api.crossref.org/works/10.1097/00002281-200311000-00015

Protection from pulmonary fibrosis in the absence of CCR2 signaling

23 March 2024

13

1 reference

https://api.crossref.org/works/10.1097/00002281-200311000-00015

Expression of C-C chemokines in bronchoalveolar lavage cells from patients with granulomatous lung diseases

23 March 2024

15

1 reference

https://api.crossref.org/works/10.1097/00002281-200311000-00015

Chemokine release from activated human dermal microvascular endothelial cells--implications for the pathophysiology of scleroderma?

23 March 2024

16

1 reference

https://api.crossref.org/works/10.1097/00002281-200311000-00015

In situ expression of cytokines and cellular adhesion molecules in the skin of patients with systemic sclerosis. Their role in early and late disease

23 March 2024

17

1 reference

https://api.crossref.org/works/10.1097/00002281-200311000-00015

Up-regulation of IL-8 secretion by alveolar macrophages from patients with fibrosing alveolitis: a subpopulation analysis

23 March 2024

18

1 reference

https://api.crossref.org/works/10.1097/00002281-200311000-00015

Thrombin upregulates interleukin-8 in lung fibroblasts via cleavage of proteolytically activated receptor-I and protein kinase C-gamma activation

23 March 2024

19

1 reference

https://api.crossref.org/works/10.1097/00002281-200311000-00015

The Journal of Rheumatology

23 March 2024

20

25

296

Kadono

1998

1 reference

https://api.crossref.org/works/10.1097/00002281-200311000-00015

CXC chemokines in angiogenesis related to pulmonary fibrosis

23 March 2024

23

1 reference

https://api.crossref.org/works/10.1097/00002281-200311000-00015

Microarray profile of differentially expressed genes in a monkey model of allergic asthma

23 March 2024

27

1 reference

https://api.crossref.org/works/10.1097/00002281-200311000-00015

Expression of the chemokine PARC mRNA in bronchoalveolar cells of patients with sarcoidosis.

23 March 2024

28

1 reference

https://api.crossref.org/works/10.1097/00002281-200311000-00015

Alternative versus classical activation of macrophages.

23 March 2024

29

1 reference

https://api.crossref.org/works/10.1097/00002281-200311000-00015

Influence of alternatively and classically activated macrophages on fibrogenic activities of human fibroblasts

23 March 2024

30

1 reference

https://api.crossref.org/works/10.1097/00002281-200311000-00015

Proteoglycan expression in bleomycin lung fibroblasts: role of transforming growth factor-beta(1) and interferon-gamma

23 March 2024

31

1 reference

https://api.crossref.org/works/10.1097/00002281-200311000-00015

Transforming growth factor beta induces fibroblast fibrillin-1 matrix formation

23 March 2024

32

1 reference

https://api.crossref.org/works/10.1097/00002281-200311000-00015

Induction of heat shock protein 47 synthesis by TGF-beta and IL-1 beta via enhancement of the heat shock element binding activity of heat shock transcription factor 1

23 March 2024

33

1 reference

https://api.crossref.org/works/10.1097/00002281-200311000-00015

Scleroderma and Smads: dysfunctional Smad family dynamics culminating in fibrosis

23 March 2024

34

1 reference

https://api.crossref.org/works/10.1097/00002281-200311000-00015

Smad3: a key player in pathogenetic mechanisms dependent on TGF-beta

23 March 2024

35

1 reference

https://api.crossref.org/works/10.1097/00002281-200311000-00015

Prostacyclin derivatives prevent the fibrotic response to TGF-beta by inhibiting the Ras/MEK/ERK pathway

23 March 2024

37

1 reference

https://api.crossref.org/works/10.1097/00002281-200311000-00015

Animal model of sclerotic skin. V: Increased expression of alpha-smooth muscle actin in fibroblastic cells in bleomycin-induced scleroderma

23 March 2024

38

1 reference

https://api.crossref.org/works/10.1097/00002281-200311000-00015

Anti-sclerotic effect of transforming growth factor-beta antibody in a mouse model of bleomycin-induced scleroderma

23 March 2024

40

1 reference

https://api.crossref.org/works/10.1097/00002281-200311000-00015

Effect of antibody to transforming growth factor beta on bleomycin induced accumulation of lung collagen in mice

23 March 2024

41

1 reference

https://api.crossref.org/works/10.1097/00002281-200311000-00015

Effects of delayed treatment with transforming growth factor-beta soluble receptor in a three-dose bleomycin model of lung fibrosis in hamsters

23 March 2024

42

1 reference

https://api.crossref.org/works/10.1097/00002281-200311000-00015

Lack of skin fibrosis in tight skin (TSK) mice with targeted mutation in the interleukin-4R alpha and transforming growth factor-beta genes.

23 March 2024

43

1 reference

https://api.crossref.org/works/10.1097/00002281-200311000-00015

Integrin-mediated activation of transforming growth factor-beta(1) in pulmonary fibrosis

23 March 2024

44

1 reference

https://api.crossref.org/works/10.1097/00002281-200311000-00015

Global analysis of gene expression in pulmonary fibrosis reveals distinct programs regulating lung inflammation and fibrosis

23 March 2024

45

1 reference

https://api.crossref.org/works/10.1097/00002281-200311000-00015

The Journal of Rheumatology

23 March 2024

46

29

2558

Kubo

2002

1 reference

https://api.crossref.org/works/10.1097/00002281-200311000-00015

Increased transcriptional activities of transforming growth factor beta receptors in scleroderma fibroblasts

23 March 2024

47

1 reference

https://api.crossref.org/works/10.1097/00002281-200311000-00015

Dysregulation of transforming growth factor beta signaling in scleroderma: overexpression of endoglin in cutaneous scleroderma fibroblasts.

23 March 2024

48

1 reference

https://api.crossref.org/works/10.1097/00002281-200311000-00015

Anti-monocyte chemoattractant protein-1 gene therapy attenuates pulmonary hypertension in rats

23 March 2024

49

1 reference

https://api.crossref.org/works/10.1097/00002281-200311000-00015

Anti-monocyte chemoattractant protein-1 gene therapy inhibits vascular remodeling in rats: blockade of MCP-1 activity after intramuscular transfer of a mutant gene inhibits vascular remodeling induced by chronic blockade of NO synthesis

23 March 2024

50

1 reference

https://api.crossref.org/works/10.1097/00002281-200311000-00015

Chemokine RANTES in Severe Pulmonary Arterial Hypertension

23 March 2024

51

1 reference

https://api.crossref.org/works/10.1097/00002281-200311000-00015

CX3C Chemokine Fractalkine in Pulmonary Arterial Hypertension

23 March 2024

52

1 reference

https://api.crossref.org/works/10.1097/00002281-200311000-00015

23 March 2024

Identifiers

1 reference

8 August 2017

1 reference